123 related articles for article (PubMed ID: 6980883)
1. Covalent modification of fourth component of human complement with primary amines. Binding studies with metastable fragment C4b and with C4.
Gorski JP; Silversmith R; Fiebeger S; Moilanen T
J Biol Chem; 1982 Sep; 257(18):10948-54. PubMed ID: 6980883
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
Isenman DE; Young JR
J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
[TBL] [Abstract][Full Text] [Related]
3. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4.
Blanchong CA; Chung EK; Rupert KL; Yang Y; Yang Z; Zhou B; Moulds JM; Yu CY
Int Immunopharmacol; 2001 Mar; 1(3):365-92. PubMed ID: 11367523
[TBL] [Abstract][Full Text] [Related]
4. The binding of human complement component C4 to antibody-antigen aggregates.
Campbell RD; Dodds AW; Porter RR
Biochem J; 1980 Jul; 189(1):67-80. PubMed ID: 6906229
[TBL] [Abstract][Full Text] [Related]
5. The fourth component of human complement treated with amines or chaotropes or frozen-thawed (C4b-like C4): interaction with C4 binding protein and cleavage by C3b/C4b inactivator.
von Zabern I; Bloom EL; Chu V; Gigli I
J Immunol; 1982 Mar; 128(3):1433-8. PubMed ID: 6976993
[TBL] [Abstract][Full Text] [Related]
6. Identification of a surface structure in the fourth component of human complement, C4, which becomes hidden upon activation by C1(-)s.
Maeda S; Takamaru Y; Fukatsu J; Nagasawa S
Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):503-8. PubMed ID: 7678736
[TBL] [Abstract][Full Text] [Related]
7. Covalent binding and hemolytic activity of complement proteins.
Law SK; Lichtenberg NA; Levine RP
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
[TBL] [Abstract][Full Text] [Related]
8. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
[TBL] [Abstract][Full Text] [Related]
9. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
[TBL] [Abstract][Full Text] [Related]
10. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
11. The role of the thioester bond in C3 and C4 in the determination of the conformational and functional states of the molecule.
Isenman DE
Ann N Y Acad Sci; 1983; 421():277-90. PubMed ID: 6202198
[TBL] [Abstract][Full Text] [Related]
12. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
13. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.
Sepp A; Dodds AW; Anderson MJ; Campbell RD; Willis AC; Law SK
Protein Sci; 1993 May; 2(5):706-16. PubMed ID: 8495193
[TBL] [Abstract][Full Text] [Related]
14. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
Villiers MB; Thielens NM; Reboul A; Colomb MG
Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
[TBL] [Abstract][Full Text] [Related]
15. Treatment of human complement components C4 and C3 with amines or chaotropic ions. Evidence of a functional and structural change that provides uncleaved C4 and C3 with properties of their soluble activated froms, C4b and C3b.
von Zabern I; Nolte R; Vogt W
Scand J Immunol; 1981; 13(5):413-31. PubMed ID: 6171865
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of the low hemolytic activity of C4 molecules from low-C4 mice with IgM-coated erythrocytes.
Dieli F; Sireci G; Lio D; Salerno A
Eur J Immunol; 1989 Sep; 19(9):1613-8. PubMed ID: 2792181
[TBL] [Abstract][Full Text] [Related]
17. Conformational changes in complement component C4 induced by activation, treatment with amines, chaotropes, or freezing-thawing, detectable by radioiodination using lactoperoxidase.
von Zabern I; Gigli I
J Immunol; 1982 Mar; 128(3):1439-42. PubMed ID: 6976994
[TBL] [Abstract][Full Text] [Related]
18. Effect of methylamine on the structure and function of the fourth component of human complement, C4.
Gorski JP; Howard JB
J Biol Chem; 1980 Nov; 255(21):10025-8. PubMed ID: 7430113
[No Abstract] [Full Text] [Related]
19. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.
Reilly BD; Levine RP; Skanes VM
J Immunol; 1991 Nov; 147(9):3018-23. PubMed ID: 1919003
[TBL] [Abstract][Full Text] [Related]
20. Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.
Isenman DE; Young JR
J Immunol; 1986 Apr; 136(7):2542-50. PubMed ID: 3512717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
